(A-B) 106 CD45.1 OT1 T cells were transferred i.v. into CD45.2+ mice, treated i.p. with 500μg of anti-CD8α or –β the next day, and immunized or infected. Spleens and lymph nodes were collected on day 5 post-infection or on day 7 post-immunization. CD8+ T cells were considered as CD45.1+ B220-. (A) Surface bound depleting mAb on OT1s was determined by staining with Goat anti-Rat IgG. (B) Remaining OT1 T cells as a percentage of lymphocytes and total numbers were calculated per spleen or pooled lymph nodes. Data representative of at least 3 independent experiments. Each point represents the average value of a mouse with 3–4 mice per group.</p
<p>A- WT and <i>Btla</i><sup>−/−</sup> mice were orally infected with 1×10<sup>9</sup> LM-OVA and 7 ...
<p>Mice were immunized as described in <a href="http://www.plosntds.org/article/info:doi/10.1371/jou...
<p>WT or <i>Hvem</i><sup>−/−</sup> mice were orally infected with 1×10<sup>9</sup> LM-OVA and the am...
(A-C) Naïve mice were treated i.p. with a total of 10μg of: anti-CD8α only, anti-CD8β only, or 5μg o...
(A-B) 106 CD45.1+ OT1 T cells were transferred i.v. into CD45.2+ mice, treated with anti-CD8α or –β ...
(A-B) 106 CD45.1 OT1 T cells were transferred i.v. into CD45.2+ mice, treated with anti-CD8α or –β t...
<p>C57BL/6 mice were treated twice with 250 µg anti-CD4 Ab (GK1.5 Harlan) two and one day prior to i...
<p>CBA/J mice were infected with an aerosolized dose of <i>Mtb</i> and from day 90–120 were treated ...
(A) Flow cytometry gating strategy: after gating on singlet and live lymphocytes, B cells were gated...
<p>BALB/c mice were intranasally infected with the indicated viruses (10<sup>4</sup> PFU) and at 11,...
<p>C57BL/6 mice infected with low dose (1×10<sup>3</sup>) and high dose (2×10<sup>6</sup>) <i>L. maj...
<p>(<b>A, B</b>) Expression of CD39 and PD-1 by CD44<sup>–</sup> naive mouse CD8<sup>+</sup> T cells...
<p>Indicated numbers of purified CD8<sup>+</sup> T cells from CD45.1<sup>+</sup> OT-I mice were adop...
<p>Immunized mice were challenge infected and at week 4 after challenge infections mice were sacrifi...
<p>Mice (3/group) which had been transplanted i.p. with 3 × 10<sup>6</sup> ID8 cells 10 days earlier...
<p>A- WT and <i>Btla</i><sup>−/−</sup> mice were orally infected with 1×10<sup>9</sup> LM-OVA and 7 ...
<p>Mice were immunized as described in <a href="http://www.plosntds.org/article/info:doi/10.1371/jou...
<p>WT or <i>Hvem</i><sup>−/−</sup> mice were orally infected with 1×10<sup>9</sup> LM-OVA and the am...
(A-C) Naïve mice were treated i.p. with a total of 10μg of: anti-CD8α only, anti-CD8β only, or 5μg o...
(A-B) 106 CD45.1+ OT1 T cells were transferred i.v. into CD45.2+ mice, treated with anti-CD8α or –β ...
(A-B) 106 CD45.1 OT1 T cells were transferred i.v. into CD45.2+ mice, treated with anti-CD8α or –β t...
<p>C57BL/6 mice were treated twice with 250 µg anti-CD4 Ab (GK1.5 Harlan) two and one day prior to i...
<p>CBA/J mice were infected with an aerosolized dose of <i>Mtb</i> and from day 90–120 were treated ...
(A) Flow cytometry gating strategy: after gating on singlet and live lymphocytes, B cells were gated...
<p>BALB/c mice were intranasally infected with the indicated viruses (10<sup>4</sup> PFU) and at 11,...
<p>C57BL/6 mice infected with low dose (1×10<sup>3</sup>) and high dose (2×10<sup>6</sup>) <i>L. maj...
<p>(<b>A, B</b>) Expression of CD39 and PD-1 by CD44<sup>–</sup> naive mouse CD8<sup>+</sup> T cells...
<p>Indicated numbers of purified CD8<sup>+</sup> T cells from CD45.1<sup>+</sup> OT-I mice were adop...
<p>Immunized mice were challenge infected and at week 4 after challenge infections mice were sacrifi...
<p>Mice (3/group) which had been transplanted i.p. with 3 × 10<sup>6</sup> ID8 cells 10 days earlier...
<p>A- WT and <i>Btla</i><sup>−/−</sup> mice were orally infected with 1×10<sup>9</sup> LM-OVA and 7 ...
<p>Mice were immunized as described in <a href="http://www.plosntds.org/article/info:doi/10.1371/jou...
<p>WT or <i>Hvem</i><sup>−/−</sup> mice were orally infected with 1×10<sup>9</sup> LM-OVA and the am...